1,824
Views
55
CrossRef citations to date
0
Altmetric
Editorial

Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy

, &
Pages 135-139 | Published online: 17 Jan 2012

Bibliography

  • Scheiber J. How can we enable drug discovery informatics for personalized healthcare. Expert Opin Drug Discov 2011;6:219-24
  • Yong WP, Innocenti F Ratain MJ. The role of pharmacogenetics in cancer therapeutics. Br J Clin Pharmacol 2006;62:35-46
  • Watson RG, McLeod HL. Pharmacogenomic contribution to drug response. Cancer J 2011;17:80-8
  • Clayton TA, Lindon JC, Cloarec O, Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 2006;440:1073-7
  • Clayton TA, Baker D, Lindon JC, Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA 2009;106:14728-33
  • Winnike JH, Wright FA, Macdonald JM, Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans. Clin Pharm 2010;88:45-51
  • Phapale PB, Kim SD, Lee HW, An integrated approach for identifying a metabolic phenotype predictive of individualized pharmacokinetics of tacrolimus. Clin Pharmacol Ther 2010;87:426-36
  • Kinross JM, Holmes E, Darzi AW, Metabolic phenotyping in monitoring of surgical patients. Lancet 2011;377:1817-19
  • Nicholson G, Rantalainen M, Maher AD, Human metabolic profiles are stably controlled by genetic and environmental variation. Mol Syst Biol 2011;7:525
  • Rezzi S, Ramadan Z, Martin F-PJ, Human metabolic phenotypes link directly to specific dietary preferences in healthy individuals. J Proteome Res 2007;6:4469-77
  • Jia W, Li H, Zhao L, Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov 2008;7:123-9
  • Wallace BD, Wang H, Lane KT, Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 2010;330:831-5
  • Yap IKS, Angley M, Veselkov KA, Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res 2010;9:2996-3004
  • Backshall A, Sharma R, Clarke SJ, Pharmacometabonomic profiling as a predictor of toxicity in patients with inoperable colorectal cancer treated with capecitabine. Clin Cancer Res 2011;17:3019-28
  • Lindon JC, Nicholson JK. Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Ann Rev Anal Chem 2008;1:45-69

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.